| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |